scispace - formally typeset
M

Melissa V. Chan

Researcher at Queen Mary University of London

Publications -  63
Citations -  1777

Melissa V. Chan is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Platelet & Platelet activation. The author has an hindex of 19, co-authored 54 publications receiving 1360 citations. Previous affiliations of Melissa V. Chan include Swansea University & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.

TL;DR: P2Y12 receptor blockade alone causes inhibition of platelet aggregation that is little enhanced by aspirin, and the antiaggregatory effects of PAM were associated with reductions in the platelet release of both TXA2 and ATP + ADP.
Journal ArticleDOI

Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.

TL;DR: In the kidney and other sites, constitutive COX-2 expression is a sterile response, independent of commensal microorganisms and not associated with activity of the inflammatory transcription factor NF-κB, which is important for normal homeostatic functions, including those important to the cardiovascular-renal system.
Journal ArticleDOI

2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

TL;DR: The writing group reaffirmed the 2015 pediatric advanced life support guideline recommendation that either lidocaine or amiodarone may be used to treat pediatric patients with shock-refractory ventricular fibrillation or pulseless ventricular tachycardia.
Journal ArticleDOI

Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.

TL;DR: There is a rapidly expanding body of evidence for important roles of hydrogen sulfide in protecting against tissue injury, reducing inflammation, and promoting repair, and there is strong evidence that novel, H2S-based therapeutics are safe and effective in animal models.